Physician

Amanda M. Laird, M.D.

According to 2025 Medicare claims, Amanda Laird, M.D. (NPI: 1851377576) practices surgical oncology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Middlesex, NJ. This provider's primary affiliated billing organization is RUTGERS HEALTH-RWJ SCLERODERMA PROGRAM (NPI: 1487688495; TIN: 223371727) and primary practice location at 08901-1928. Laird is affiliated with the Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Laird's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 75 traditional Medicare patients, billed 134 HCPCS/CPT codes, and received $22,779 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 56 prescription claims across 22 beneficiaries totaling $383 in drug costs, led by Ondansetron Hcl (Ondansetron Hcl). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $23,894 and ending at $22,779. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,023 and ending at $383. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$19K$39K2015 Medicare payment: $23,894 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $26,197 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $16,088 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $34,775 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $38,827 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $35,402 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $19,717 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $29,329 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $32,477 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $22,779 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201561128$23,894
201671149$26,197
20174489$16,088
201868142$34,775
201977138$38,827
202055113$35,402
20214883$19,717
2022105157$29,329
2023111191$32,477
202475134$22,779

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.8K$3.6K2015 Drug cost: $2,023 (USD; Tot_Drug_Cst)2016 Drug cost: $2,416 (USD; Tot_Drug_Cst)2017 Drug cost: $1,065 (USD; Tot_Drug_Cst)2018 Drug cost: $446 (USD; Tot_Drug_Cst)2019 Drug cost: $757 (USD; Tot_Drug_Cst)2020 Drug cost: $534 (USD; Tot_Drug_Cst)2021 Drug cost: $3,633 (USD; Tot_Drug_Cst)2022 Drug cost: $464 (USD; Tot_Drug_Cst)2023 Drug cost: $2,436 (USD; Tot_Drug_Cst)2024 Drug cost: $383 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201562121$2,023
201647100$2,416
2017N/R23$1,065
20182051$446
20193272$757
20202352$534
20211432$3,633
20222960$464
20234188$2,436
20242256$383

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more3939$103
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more3333$43

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Ondansetron HclOndansetron Hcl12115$70
Levothyroxine SodiumLevothyroxine Sodium211,410$63
Tramadol HclTramadol Hcl1561$31

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Amanda M. Laird, M.D.?

Tedicare shows public-source Medicare data for Amanda M. Laird, M.D. (NPI 1851377576), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amanda M. Laird, M.D. have ACO affiliation data?

Amanda M. Laird, M.D. is shown with ACO affiliation data for Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Amanda M. Laird, M.D.?

Amanda M. Laird, M.D. is linked to RUTGERS HEALTH-RWJ SCLERODERMA PROGRAM (billing NPI 1487688495) in the available physician profile data.

Does Amanda M. Laird, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.